Legion Partners Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36M | Hold |
4,431,823
| – | – | 21.63% | 2 |
|
|
2025
Q1 | $31.2M | Hold |
4,431,823
| – | – | 20.71% | 2 |
|
|
2024
Q4 | $32.9M | Buy |
4,431,823
+1,463,414
| +49% | +$10.9M | 19.21% | 3 |
|
|
2024
Q3 | $14.6M | Hold |
2,968,409
| – | – | 5.08% | 8 |
|
|
2024
Q2 | $15.2M | Buy |
2,968,409
+18,182
| +0.6% | +$93.3K | 4.7% | 6 |
|
|
2024
Q1 | $15.7M | Buy |
2,950,227
+9,887
| +0.3% | +$52.5K | 3.63% | 11 |
|
|
2023
Q4 | $18.2M | Hold |
2,940,340
| – | – | 4.74% | 9 |
|
|
2023
Q3 | $22.2M | Hold |
2,940,340
| – | – | 6.67% | 7 |
|
|
2023
Q2 | $28.4M | Hold |
2,940,340
| – | – | 8.31% | 7 |
|
|
2023
Q1 | $11.1M | Hold |
2,940,340
| – | – | 3.27% | 11 |
|
|
2022
Q4 | $19.1M | Hold |
2,940,340
| – | – | 5.84% | 8 |
|
|
2022
Q3 | $26.1M | Hold |
2,940,340
| – | – | 9.44% | 7 |
|
|
2022
Q2 | $29.3M | Hold |
2,940,340
| – | – | 7.61% | 5 |
|
|
2022
Q1 | $34M | Buy |
2,940,340
+12,250
| +0.4% | +$142K | 6.25% | 8 |
|
|
2021
Q4 | $32.5M | Hold |
2,928,090
| – | – | 6.08% | 7 |
|
|
2021
Q3 | $27M | Hold |
2,928,090
| – | – | 5.55% | 8 |
|
|
2021
Q2 | $32.9M | Hold |
2,928,090
| – | – | 6.62% | 7 |
|
|
2021
Q1 | $31M | Buy |
2,928,090
+23,750
| +0.8% | +$252K | 6.22% | 6 |
|
|
2020
Q4 | $31.5M | Hold |
2,904,340
| – | – | 8.2% | 6 |
|
|
2020
Q3 | $28.2M | Hold |
2,904,340
| – | – | 6.76% | 6 |
|
|
2020
Q2 | $23.1M | Buy |
2,904,340
+522,847
| +22% | +$4.16M | 6.47% | 5 |
|
|
2020
Q1 | $20.7M | Buy |
2,381,493
+1,205,388
| +102% | +$10.5M | 8.73% | 5 |
|
|
2019
Q4 | $13.3M | Buy |
1,176,105
+566,245
| +93% | +$6.4M | 3.45% | 10 |
|
|
2019
Q3 | $6.63M | Buy |
+609,860
| New | +$6.63M | 1.63% | 10 |
|